Interactions of VIP, Secretin and PACAP1-38 with Phospholipids: A Biological Paradox Revisited

E-ISSN： 1873-4286|9|12|1005-1012

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.12, 2003-05, pp. : 1005-1012

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Passage of VIP / PACAP / Secretin Family Across the Blood-Brain Barrier: Therapeutic Effects

Current Pharmaceutical Design, Vol. 10, Iss. 12, 2004-05 ,pp. : 1325-1340

Bentham Science Publishers

Access to resources Recommend Favorite

VIP and PACAP in pain and inflammation

By Said S.I.S.I.

Trends in Pharmacological Sciences, Vol. 21, Iss. 2, 2000-02 ,pp. : 57-57

Elsevier

Access to resources Recommend Favorite

Differences in Biological Activity Between PACAP27 and VIP in PC12 Cells Depend on Their N-Terminal Structures

By Onoue Satomi Nagano Yumiko Endo Kosuke Yajima Takehiko Kashimoto Kazuhisa

Pharmacology Communications, Vol. 12, Iss. 4, 2002-10 ,pp. : 205-213

Taylor & Francis Ltd

Access to resources Recommend Favorite

VIP and PACAP: very important in pain?

By Dickinson T. Fleetwood-Walker S.M.

Trends in Pharmacological Sciences, Vol. 20, Iss. 8, 1999-08 ,pp. : 324-329

Elsevier

Access to resources Recommend Favorite

Interaction of lipophilic VIP derivatives with recombinant VIP 1 /PACAP and VIP 2 /PACAP receptors

By Gourlet P. Rathe J. De Neef P. Cnudde J. Vandermeers-Piret M.-C. Waelbroeck M. Robberecht P.

European Journal of Pharmacology, Vol. 354, Iss. 1, 1998-07 ,pp. : 105-111

Elsevier

Access to resources Recommend Favorite